Literature DB >> 26091268

Rational drug design: Tuning kinase inhibitor residence time.

Megan Cully.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26091268     DOI： 10.1038/nrd4673

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Prolonged and tunable residence time using reversible covalent kinase inhibitors.

Authors:  J Michael Bradshaw; Jesse M McFarland; Ville O Paavilainen; Angelina Bisconte; Danny Tam; Vernon T Phan; Sergei Romanov; David Finkle; Jin Shu; Vaishali Patel; Tony Ton; Xiaoyan Li; David G Loughhead; Philip A Nunn; Dane E Karr; Mary E Gerritsen; Jens Oliver Funk; Timothy D Owens; Erik Verner; Ken A Brameld; Ronald J Hill; David M Goldstein; Jack Taunton
Journal:  Nat Chem Biol       Date:  2015-05-25       Impact factor: 15.040
  1 in total
  3 in total

Review 1.  Kinase inhibitors: the road ahead.

Authors:  Fleur M Ferguson; Nathanael S Gray
Journal:  Nat Rev Drug Discov       Date:  2018-03-16       Impact factor: 84.694

Review 2.  Small molecule inhibitors targeting the cancers.

Authors:  Gui-Hong Liu; Tao Chen; Xin Zhang; Xue-Lei Ma; Hua-Shan Shi
Journal:  MedComm (2020)       Date:  2022-10-13

Review 3.  Docking covalent targets for drug discovery: stimulating the computer-aided drug design community of possible pitfalls and erroneous practices.

Authors:  Abdul-Quddus Kehinde Oyedele; Abdeen Tunde Ogunlana; Ibrahim Damilare Boyenle; Ayodeji Oluwadamilare Adeyemi; Temionu Oluwakemi Rita; Temitope Isaac Adelusi; Misbaudeen Abdul-Hammed; Oluwabamise Emmanuel Elegbeleye; Tope Tunji Odunitan
Journal:  Mol Divers       Date:  2022-09-04       Impact factor: 3.364
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.